Australia vs France: Cause of death, by non-communicable diseases, ages 15-59
Australia
76.3%
in 2021
France
76.3%
in 2021
Australia rank
20th
France rank
19th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Australia
- France
How they compare
France currently reports 76.3% against 76.3% in Australia, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Australia ahead.
Australia ranks 20th and France ranks 19th of 185 countries.
Across the 3 decades both report, Australia averaged higher in 2 and France in 1.
Head to head by decade
| Decade | Australia | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.1% | 73.9% | 0.2% | Australia |
| 2010s | 75.4% | 78.5% | 3.1% | France |
| 2020s | 76.4% | 75.9% | 0.5% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Australia or France?
- France, at 76.3% against 76.3% in Australia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Australia and France?
- 0.0%, with France ahead.
- How many years of comparable data are there for Australia and France?
- 6 years are reported by both, from 2000 to 2021.
- How do Australia and France rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Australia ranks 20th and France ranks 19th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.